Minor adverse events · people with active UC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · people with active UC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · people with active UC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease improvement (based on clinical scores) · people with active UC
Probiotics may leads to higher disease improvement (based on clinical scores) compared with placebo (low certainty).
1 finding from 1 review
Minor adverse events · people with active UC
It is very uncertain whether probiotics changes minor adverse events compared with placebo (very low certainty).
1 finding from 1 review
Serious adverse events · people with active UC
It is very uncertain whether probiotics changes serious adverse events compared with placebo (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · people with active UC
Probiotics showed no clear difference in withdrawal due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Clinical remission · people with active UC
Probiotics showed no clear difference in clinical remission compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (low certainty).
1 finding from 1 review
Minor adverse events · people with active UC
It is very uncertain whether probiotics changes minor adverse events compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (very low certainty).
1 finding from 1 review
Serious adverse events · people with active UC
It is very uncertain whether probiotics changes serious adverse events compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · people with active UC
It is very uncertain whether probiotics changes withdrawal due to adverse events compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (very low certainty).
1 finding from 1 review
Health‐related quality of life · adults (>= 18 years) with an irreversible visual impairment
1 finding from 1 review
Vision‐related quality of life · adults (>= 18 years) with an irreversible visual impairment
1 finding from 1 review
Adverse events · adults (>= 18 years) with an irreversible visual impairment
1 finding from 1 review
Health‐related quality of life · adults (>= 18 years) with an irreversible visual impairment
1 finding from 1 review
Vision‐related quality of life · adults (>= 18 years) with an irreversible visual impairment
1 finding from 1 review
Adverse events · adults (>= 18 years) with an irreversible visual impairment
1 finding from 1 review
Health‐related quality of life · adults (>= 18 years) with an irreversible visual impairment
1 finding from 1 review
Vision‐related quality of life · adults (>= 18 years) with an irreversible visual impairment
1 finding from 1 review
Adverse events · adults (>= 18 years) with an irreversible visual impairment
1 finding from 1 review